AbCellera Biologics (ABCL)
Discovers antibodies for partners and advances its own clinical candidates.
$12.22
vs last close−0.44 (−3.44%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 37.66% | 115.46M shares | |
|---|---|---|---|
| 167 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 19.46% | 59.67M shares | |
| 5 holders · as of Aug 24, 2026 | |||
| Strategic holders | 18.31% | 56.13M shares | |
| 1 holder · as of Mar 2, 2026 | |||
| Other | ≈ 24.57% | 75.34M shares | |
| remainder | |||
306.61M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
167 holders · 115.46M shares · 40 new positions · 77 increased · 53 reduced · 27 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 33.01M | 10.77% | +2.74M | Aug 14, 2026 |
| Capital World Investors | 13.59M | 4.43% | +227.3K | Aug 12, 2026 |
| Two Sigma Investments, LP | 10.44M | 3.40% | −124.6K | Aug 14, 2026 |
| TD Waterhouse Canada Inc. | 9.57M | 3.12% | +3.5K | Jul 27, 2026 |
| Bank of America Corp /DE/ | 6.14M | 2.00% | +3.14M | Aug 14, 2026 |
| UBS Asset Management Americas Inc | 4.32M | 1.41% | −3.26M | Aug 13, 2026 |
| Arrowmark Colorado Holdings LLC | 4.11M | 1.34% | 0 | Aug 13, 2026 |
| BlackRock, Inc. | 3.81M | 1.24% | −234.9K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 10.80% | 33.01M | 13G | May 7, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 24, 2026 | Michael R. Haydendirector | Purchase | 53,613 | $10.64 | 1,373,397 |
| Aug 18, 2026 | John S. Montalbanodirector | Purchase | 10,000 | $11.03 | 251,000 |
| Aug 14, 2026 | Andrew Boothofficer: Chief Financial Officer | Purchase | 37,200 | $10.32 | 482,800 |
| Aug 12, 2026 | Michael R. Haydendirector | Purchase | 46,387 | $10.37 | 1,319,784 |
| May 14, 2026 | John S. Montalbanodirector | Purchase | 20,000 | $4.77 | 241,000 |
| Feb 27, 2026 | Thermopylae Holdings Ltd.10 percent owner | Purchase | 38,000 | $3.44 | 56,134,097 |
| Feb 27, 2026 | Andrew Boothofficer: Chief Financial Officer | Purchase | 42,600 | $3.42 | 195,600 |
| Feb 26, 2026 | Thermopylae Holdings Ltd.10 percent owner | Purchase | 177,457 | $3.27 | 56,096,097 |
| Nov 26, 2025 | John S. Montalbanodirector | Purchase | 50,000 | $3.57 | 221,000 |
House and Senate disclosures
Not reported.